Rigel Pharmaceuticals (RIGL) PT Raised to $11 at Piper Jaffray
Tweet Send to a Friend
Piper Jaffray analyst Joshua Schimmer reiterated an Overweight rating on Rigel ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
